February 24, 2016 by Chain Drug Review
FDA, FDA commissioner, Food and Drug Administration, Margaret Hamburg, Robert Califf, Stephen Ostroff, Sylvia Burwell
Leading Headlines, Pharmacy, Retail News
WASHINGTON — The U.S. Senate overwhelmingly confirmed Dr. Robert Califf as commissioner of the Food and Drug Administration. Califf, who was deputy commissioner for medical products and tobacco, was nominated as FDA commissioner by President Barack Obama in mid-September. No significant opposition was expected for his confirmation hearing on Tuesday, as the Senate voted 89-4
September 16, 2015 by Chain Drug Review
Barack Obama, FDA commissioner, Food and Drug Administration, Margaret Hamburg, Robert Califf, Stephen Ostroff
Leading Headlines, Pharmacy, Retail News
WASHINGTON — The Food and Drug Administration’s current deputy commissioner for medical products and tobacco is likely to become the organization’s next commissioner. Dr. Robert Califf, a cardiologist and clinical researcher long affiliated with Duke University, on Tuesday was nominated as FDA commissioner by President Barack Obama. On Wednesday, his nomination was sent to the
March 6, 2015 by John Schultz and Chain Drug Review
biologics, biosimilar, filgrastim, Food and Drug Administration, Margaret Hamburg, Sandoz, Zarxio
News, Pharmacy, Retail News
WASHINGTON — Zarxio (filgrastim), a cancer treatment from Sandoz Inc., has become the first biosimilar product approved in the United States. The Food and Drug Administration announced its approval of Zarxio, a biosimilar to Neupogen, an oncology product from Amgen Inc., on Friday. The move is being hailed as a watershed event that paves the
February 16, 2015 by Mark Baumgartner and Chain Drug Review
Food and Drug Administration, Francis Collins, Generic Pharmaceutical Association, Margaret Hamburg, National Institutes of Health, Ralph Neas, Stephen Ostroff
2015, Issue 02-16-2015, News, Pharmacy
WASHINGTON — Dr. Margaret Hamburg, commissioner of the Food and Drug Administration, will step aside next month after nearly six years at the helm of the agency overseeing many of the nation’s most contentious public policy issues and products representing about 20% of every dollar spent by consumers. Hamburg, 59, said her decision to step
February 5, 2015 by Chain Drug Review
FDA, FDA commissioner, Food and Drug Administration, Margaret Hamburg, Stephen Ostroff
Pharmacy, Retail News
Margaret Hamburg WASHINGTON — Margaret Hamburg reportedly is stepping down as commissioner of the Food and Drug Administration. Published reports said Thursday that the 59-year-old Hamburg is slated to leave the FDA commissioner post at the end of March and that the Obama administration plans to make a formal announcement on Friday. Plans call for